# Treatment of In-Stent Restenosis 2 Study

> **NCT03667313** · PHASE3 · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 200 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **COMBINATION_PRODUCT:** sirolimus-eluting balloon (SEB) MagicTouch
- **COMBINATION_PRODUCT:** paclitaxel-eluting balloon (PEB) Sequent Please

## Key facts

- **NCT ID:** NCT03667313
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667313, "Treatment of In-Stent Restenosis 2 Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03667313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*